Read the full article below. Microbiotica unveils multiple mechanisms by which MB310, in clinical development for the treatment of ulcerative colitis, protects the intestinal...
EMIH is pleased to see Dr. Marty Makary, newly appointed FDA Commissioner, highlight the role of the gut microbiome in human health during his recent interview. His emphasis on the microbiome’s influence aligns strongly with EMIH’s mission to accelerate the...
We caught up with Hervé Affagard, CEO of MaaT Pharma and President of EMIH for an exclusive interview to discuss the far reaching impact of the ARES Phase 3 unprecedented results Read the full interview below. Hervé Affagard talks Phase 3 results, the regulatory...
The event will take place on January 23, 2025, in Lyon This day offers a unique opportunity for microbiota stakeholders (academics, clinicians, and industry leaders) to gather around current, innovation-driven topics. Enjoy a 30% discount to join discussions on the...
Paris – France – September 25 2024, 4:00 pm CET – The European Microbiome Innovation for Health (EMIH) association Microbiome Times Magazine, the microbiome industry’s leading B2B publication, is pleased to announce its collaboration with the...
